Oxford Quantum Circuits Secures $260 Million in Latest Series C Funding Round
Oxford Quantum Circuits secured $260 million in its latest Series C, adding another data point to the Healthcare & Life Sciences funding market.
Oxford Quantum Circuits Raises $260 million in Funding
Oxford Quantum Circuits is a Digital Health company focused on scale globally competitive deep tech companies.
Investors Behind the Funding
The round was backed by Bullhound Capital. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.
Company Profile and Market Context
Oxford Quantum Circuits operates in Healthcare & Life Sciences. Oxford Quantum Circuits's Series C round shows investors are still backing digital health platforms with real scale narratives. At $260M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.
Strategic Use of Funds
scale globally competitive deep tech companies
Looking Ahead
Oxford Quantum Circuits lands "coming-of-age" £260M funding round
Source reference: original announcement/article.
View Oxford Quantum Circuits's full profile and funding history on Funding Intelligence →